Free shipping across Canada on orders over $200 CAD Shop now

Quality you can put in a methods section.

Every Helixa vial is sent to Testides and Peptide Test Canada, independent third‑party testing laboratories — so you get documented proof of identity and purity for the exact batch you receive.

Independent testing

Every batch is tested by Testides and Peptide Test Canada

We send vials from every lot to Testides and Peptide Test Canada, professional third‑party testing company. Nothing is released for sale until it passes.

HPLC purity

High‑performance liquid chromatography confirms purity and quantifies impurities.

Mass spectrometry

Molecular‑weight confirmation verifies peptide identity against the target.

Appearance & solubility

Visual and reconstitution checks confirm expected physical characteristics.

Documented results

Testides and Peptide Test Canada results are compiled into a batch‑specific certificate of analysis.

Our process

From lot to release

Sent for testing

Representative vials from each lot are sent to Testides and Peptide Test Canada for independent analysis.

Purity analysis

Testides and Peptide Test Canada run HPLC to quantify purity and flag impurities against our release threshold.

Identity check

Mass spectrometry confirms the compound matches its target molecular weight.

Documentation & release

Passing lots receive a batch‑specific COA, then are sealed and released for fulfilment.

Certificates of analysis

Every batch, fully documented.

A certificate of analysis is your record of exactly what you received — including the results from Testides and Peptide Test Canada for that specific batch. Each COA identifies the compound, its batch, the analytical methods used, and the measured results, so your data has a documented starting point.

  • Compound & batch identifier
  • Measured HPLC purity & MS identity
  • Tested by Testides and Peptide Test Canada · batch release date
Report Overview Complete
Report NumberGU-RETA-10-052226-02
Test DateMay 29, 2026
Peptide NameRetatrutide
Date Sample ReceivedMay 29, 2026
Analysis MethodHPLC-UV 214nm
Date TestedJun 4, 2026
AppearanceWhite Lyophilized Powder
Date ReportedJun 5, 2026
ClientHelixa Biotech
Purity99.96%
VendorHelixa Biotech
Amount12.63 mg
Lot NumberAPC-RT-WHT
Endotoxin Result< 0.125 EU/mLKinetic LAL (USP <85>)Endotoxin not detected (0.125 EU/mL) at validated 1:16 dilution (3.0 mL reconstituted vial).
Tests Requested HPLC Complete Endotoxin Complete

Questions about our testing?

Our team is happy to walk you through the testing process and your documentation.